News
13 February, 2023 - 16:40 (CET)
Alerts
M
New Invitation for Expression of Interest (EOI) to manufacturers of Antimalarial Medicines.
The following products/formulations were added (marked in bold under the EOI sections):
3. Artemisinin-based single-ingredient formulations
- Artesunate, powder for injection 30 mg; 60 mg; 120 mg; 180 mg (vial) - Addition of "180 mg"
5 . Other antimalarial medicines
- Sulfadoxine/Pyrimethamine
-
tablets 500 mg/25 mg (scored, or scored and dispersible) - Addition of "or scored and dispersible"
-
- Quinine Injection, 300 mg/mL (hydrochloride) in 2 mL ampoule